These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 27754718)

  • 1. Investigational drugs in dry eye disease.
    Nebbioso M; Fameli V; Gharbiya M; Sacchetti M; Zicari AM; Lambiase A
    Expert Opin Investig Drugs; 2016 Dec; 25(12):1437-1446. PubMed ID: 27754718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and content validity assessment of the Dry Eye Disease Questionnaire in patients with dry eye disease, meibomian gland dysfunction, and Sjögren's syndrome dry eye disease.
    Sloesen B; Young A; Forde K; Hodson N; Bentley S; Walsh O; Naujoks C; O'Brien P; Sharma G
    J Patient Rep Outcomes; 2023 Jul; 7(1):64. PubMed ID: 37405617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sjögren's Syndrome, Non-Sjögren's Syndrome, and Graft-Versus-Host Disease Related Dry Eye.
    Ogawa Y
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES71-DES79. PubMed ID: 30481809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen deficiency, Meibomian gland dysfunction, and evaporative dry eye.
    Sullivan DA; Sullivan BD; Evans JE; Schirra F; Yamagami H; Liu M; Richards SM; Suzuki T; Schaumberg DA; Sullivan RM; Dana MR
    Ann N Y Acad Sci; 2002 Jun; 966():211-22. PubMed ID: 12114274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Sjögren's syndrome dry eye similar to dry eye caused by other etiologies? Discriminating different diseases by dry eye tests.
    Garcia DM; Reis de Oliveira F; Módulo CM; Faustino J; Barbosa AP; Alves M; Rocha EM
    PLoS One; 2018; 13(12):e0208420. PubMed ID: 30507949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sjogren's syndrome from the perspective of ophthalmology.
    Kuklinski E; Asbell PA
    Clin Immunol; 2017 Sep; 182():55-61. PubMed ID: 28476437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists.
    Sheppard J; Shen Lee B; Periman LM
    Ann Med; 2023 Dec; 55(1):241-252. PubMed ID: 36576348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Customary practices in the monitoring of dry eye disease in Sjogren's syndrome.
    Acs M; Caffery B; Barnett M; Edmonds C; Johnson-Tong L; Maharaj R; Pemberton B; Papinski D; Harthan J; Srinivasan S
    J Optom; 2018; 11(4):232-241. PubMed ID: 30017867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation.
    Cordero-Coma M; Anzaar F; Sobrin L; Foster CS
    Ocul Immunol Inflamm; 2007; 15(2):99-104. PubMed ID: 17558834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity of clinical dry eye manifestations influences protein expression in tear fluid of patients with primary Sjögren's syndrome.
    Aqrawi LA; Chen X; Jensen JL; Morthen MK; Thiede B; Utheim ØA; Palm Ø; Tashbayev B; Utheim TP; Galtung HK
    PLoS One; 2018; 13(10):e0205762. PubMed ID: 30312344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical guidelines for management of dry eye associated with Sjögren disease.
    Foulks GN; Forstot SL; Donshik PC; Forstot JZ; Goldstein MH; Lemp MA; Nelson JD; Nichols KK; Pflugfelder SC; Tanzer JM; Asbell P; Hammitt K; Jacobs DS
    Ocul Surf; 2015 Apr; 13(2):118-32. PubMed ID: 25881996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren's syndrome.
    Yokoi N; Sonomura Y; Kato H; Komuro A; Kinoshita S
    Eye (Lond); 2015 Sep; 29(9):1204-12. PubMed ID: 26160526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rethinking dry eye disease: a perspective on clinical implications.
    Bron AJ; Tomlinson A; Foulks GN; Pepose JS; Baudouin C; Geerling G; Nichols KK; Lemp MA
    Ocul Surf; 2014 Apr; 12(2 Suppl):S1-31. PubMed ID: 24725379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tear Proteomics Approach to Monitoring Sjögren Syndrome or Dry Eye Disease.
    Kuo MT; Fang PC; Chao TL; Chen A; Lai YH; Huang YT; Tseng CY
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current treatments of xerophthalmia in Sjögren's syndrome].
    Baudouin C; Pisella PJ; Brignole F
    Rev Med Interne; 2004 May; 25(5):376-82. PubMed ID: 15110955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meibomian gland dysfunction and primary Sjögren's syndrome dry eye: a protocol for systematic review and meta-analysis.
    Zi C; Huang Q; Ren Y; Yao H; He T; Gao Y
    BMJ Open; 2021 Dec; 11(12):e048336. PubMed ID: 35044322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tear film aberration dynamics and vision-related quality of life in patients with dry eye disease.
    Denoyer A; Rabut G; Baudouin C
    Ophthalmology; 2012 Sep; 119(9):1811-8. PubMed ID: 22591770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in mesenchymal stem cell-derived extracellular vesicles therapy for Sjogren's syndrome-related dry eye disease.
    Li SJ; Cheng RJ; Wei SX; Xia ZJ; Pu YY; Liu Y
    Exp Eye Res; 2023 Dec; 237():109716. PubMed ID: 37951337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic evaluation of diquafosol tetrasodium for the treatment of Sjögren's syndrome.
    Bremond-Gignac D; Gicquel JJ; Chiambaretta F
    Expert Opin Drug Metab Toxicol; 2014 Jun; 10(6):905-13. PubMed ID: 24797483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential diagnosis of dry eye conditions.
    Pflugfelder SC
    Adv Dent Res; 1996 Apr; 10(1):9-12. PubMed ID: 8934916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.